Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

ICA-27243

🥰Excellent
Catalog No. T15545Cas No. 325457-89-4

ICA-27243 is less effective at activating KCNQ4 and KCNQ3/Q5. ICA-27243 is a potent and orally active KCNQ2/Q3 potassium channel opener (EC50: 0.38 μM). ICA-27243 also has antiepileptic and anticonvulsant effects.

ICA-27243

ICA-27243

🥰Excellent
Purity: 99.79%
Catalog No. T15545Cas No. 325457-89-4
ICA-27243 is less effective at activating KCNQ4 and KCNQ3/Q5. ICA-27243 is a potent and orally active KCNQ2/Q3 potassium channel opener (EC50: 0.38 μM). ICA-27243 also has antiepileptic and anticonvulsant effects.
Pack SizePriceAvailabilityQuantity
2 mg$35In Stock
5 mg$56In Stock
10 mg$89In Stock
25 mg$179In Stock
50 mg$313In Stock
100 mg$455In Stock
1 mL x 10 mM (in DMSO)$62In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "ICA-27243"

Select Batch
Purity:99.79%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
ICA-27243 is less effective at activating KCNQ4 and KCNQ3/Q5. ICA-27243 is a potent and orally active KCNQ2/Q3 potassium channel opener (EC50: 0.38 μM). ICA-27243 also has antiepileptic and anticonvulsant effects.
Targets&IC50
KCNQ2/Q3 K+ channel:0.38 μM (EC50)
In vitro
ICA-27243 increases both 86Rb+ efflux (EC50 = 0.2 μM) and whole-cell currents in Chinese hamster ovary cells stably expressing heteromultimeric KCNQ2/Q3 channels (EC50 = 0.4 μM). ICA-27243 produces membrane potential hyperpolarization that could be prevented by coadministration with the M-current inhibitors XE-991 and Linopirdine, in SH-SY5Y human neuroblastoma cells [1].
In vivo
In the mouse maximal electroshock epilepsy model, ICA-27243 (1-100 mg/kg; oral administration; male CD-1 mice) has anticonvulsant activity (ED50: 8.4 mg/kg)[1].
Chemical Properties
Molecular Weight268.65
FormulaC12H7ClF2N2O
Cas No.325457-89-4
SmilesFc1ccc(cc1F)C(=O)Nc1ccc(Cl)nc1
Relative Density.1.476 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 247 mg/mL (919.41 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.7223 mL18.6116 mL37.2232 mL186.1158 mL
5 mM0.7445 mL3.7223 mL7.4446 mL37.2232 mL
10 mM0.3722 mL1.8612 mL3.7223 mL18.6116 mL
20 mM0.1861 mL0.9306 mL1.8612 mL9.3058 mL
50 mM0.0744 mL0.3722 mL0.7445 mL3.7223 mL
100 mM0.0372 mL0.1861 mL0.3722 mL1.8612 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ICA-27243 | purchase ICA-27243 | ICA-27243 cost | order ICA-27243 | ICA-27243 chemical structure | ICA-27243 in vivo | ICA-27243 in vitro | ICA-27243 formula | ICA-27243 molecular weight